Federal award
INO THERAPEUTICS LLC
W91YU011F0018
Contract
Obligated and Ceiling
- Obligated (net)
- $390,138.56
- Ceiling (potential value, not spending)
- $390,138.56
- Current value
- $390,138.56
- Gross positive obligations
- $518,443.87
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- INO THERAPEUTICS LLC · XXQHL619FUN6
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- MALLINCKRODT INC · M5E9ZRMJANX7
- Awarding agency
- Department of War · sub-agency 2100 · office W91YU0
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- Q999 · MEDICAL- OTHER
- Industry (NAICS)
- 325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
- PIID
- W91YU011F0018
- Parent vehicle (IDV PIID)
- V797P5186B
- Award type code
- C
- Actions
- 27 · Dec 28, 2010 to May 14, 2020
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History27
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| May 14, 2020 | FY2020 | P00027 | M | $9,522.22 | — |
| May 6, 2020 | FY2020 | P00026 | F | −$18,698.08 | — |
| Dec 12, 2019 | FY2020 | P00025 | F | −$17,954.53 | — |
| Dec 4, 2018 | FY2019 | P00024 | F | −$26,511.42 | — |
| Nov 30, 2015 | FY2016 | P00023 | C | $12,136.32 | — |
| Sep 23, 2015 | FY2015 | P00022 | D | $55,046.88 | — |
| Sep 21, 2015 | FY2015 | P00021 | D | $0.00 | — |
| Sep 11, 2015 | FY2015 | P00020 | D | $680.38 | — |
| Aug 6, 2015 | FY2015 | P00019 | D | $59,968.56 | — |
| Jun 15, 2015 | FY2015 | P00018 | D | $12,216.30 | — |
| Nov 20, 2014 | FY2015 | P00017 | C | $57,719.65 | — |
| Sep 23, 2014 | FY2014 | P00016 | G | $0.00 | — |
| Mar 10, 2014 | FY2014 | P00015 | D | $11,718.75 | — |
| Feb 5, 2014 | FY2014 | P00014 | M | $57,719.65 | — |
| Jun 20, 2013 | FY2013 | P00013 | G | $0.00 | — |
| Mar 5, 2013 | FY2013 | P00012 | M | $43,335.45 | — |
| Feb 28, 2013 | FY2013 | P00011 | D | −$43,362.44 | — |
| Feb 11, 2013 | FY2013 | P00010 | D | $4,271.41 | — |
| Nov 5, 2012 | FY2013 | P00009 | C | $57,796.20 | — |
| Sep 24, 2012 | FY2012 | P00008 | D | $24,999.95 | — |
| Jul 10, 2012 | FY2012 | P00007 | D | −$38.57 | — |
| May 30, 2012 | FY2012 | P00006 | G | $0.00 | — |
| Dec 20, 2011 | FY2012 | P00005 | C | $55,632.15 | — |
| Nov 1, 2011 | FY2012 | P00004 | D | −$21,692.42 | — |
| May 19, 2011 | FY2011 | P00002 | G | $0.00 | — |
| Jan 18, 2011 | FY2011 | P00001 | D | −$47.85 | — |
| Dec 28, 2010 | FY2011 | 0 | — | $55,680.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.